Results 51 to 60 of about 177,041 (162)

Amelioration of High Fructose-Induced Cardiac Hypertrophy by Naringin

, 2018
Heart failure is a frequent unfavorable outcome of pathological cardiac hypertrophy. Recent increase in dietary fructose consumption mirrors the rise in prevalence of cardiovascular diseases such as cardiac hypertrophy leading to concerns raised by ...
Jin Hyup Lee, Jae Kyeom Kim, Hyeong Jun Ku, Jung Hyun Park, Jeen-Woo Park   +4 more
core   +1 more source

Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy via suppression of Gh

, 2010
Statins have recently been shown to produce anti-cardiac hypertrophic effects via the regulation of small GTPases. However, the effects of statins on G protein-mediated cardiac hypertrophy, which is the main pathway of cardiac hypertrophy, have not yet ...
황기철, 장양수, 최의영, 정남식   +3 more
core   +1 more source

The role of Telomeres in the development of Cardiac Hypertrophy

, 2017
Doctor of PhilosophyThe overall aim of this thesis was to determine the role of telomeres in the development of cardiac hypertrophy.
Booth, Scott
core   +1 more source

IKKi deficiency promotes pressure overload-induced cardiac hypertrophy and fibrosis.

, 2013
The inducible IκB kinase (IKKi/IKKε) is a recently described serine-threonine IKK-related kinase. Previous studies have reported the role of IKKi in infectious diseases and cancer.
Hua-Wen Gan, FangFang Li, Qing-Qing Wu, Hong-Liang Li, Zhen-Guo Ma, Heng Zhou, Jia Dai, Lu Gao, Rui Zhang, Yuan Yuan, Qi-Zhu Tang, Wei Deng, Jing Zong, Di-Fei Shen, Zhou-Yan Bian   +14 more
core   +1 more source

Calcineurin gene expression level in cardiac hypertrophy

, 2011
Cardiac hypertrophy is an independent risk factor for future morbidity and mortality. Recent investigations have centered on identifying the molecular signaling pathways that regulate cardiomyocyte reactivity that lead to pathologic hypertrophic programs.
Ji Fang He
core  

Histone Deacetylase 7 protects against pathologic cardiac hypertrophy. [PDF]

J Mol Cell Cardiol
Bu J, Hand SM, Guo S, Jang J, Li D.
europepmc   +1 more source

Remodelling in Cardiac Hypertrophy: Implications for Arrhythmogenesis

High blood pressure (HBP) affects 1 in 3 adults. Cardiac hypertrophy (thickened heart muscles) is a common condition seen in HBP. This research seeks to study the underlying changes in electrical, structural and molecular properties of the heart that may

core  

Histamine N-methyltransferase upregulation, cardiac hypertrophy, and heart failure. [PDF]

Eur Heart J
Zhang J, Jiang H, Liu L, Li X, Hong W, Xu L, Dong Z, Xu Z, Gao J, Sun X, Luo W, Liu J, Song Y, Wang P, Zhang J, Cui Y, Huang L, Zhou X, Zhang Y, Hu K, Yang J, Ge J, Sun A.   +22 more
europepmc   +1 more source

Sam68 Exacerbates Pathologic Cardiac Hypertrophy by Suppressing Cardiomyocyte Glucose Oxidation. [PDF]

Circulation
An J, Han C, Jiang Y, Shi J, Li H, Wang C, Huang J, Xu S, Ni J, Cao Y, Feng Y, Lyu Q, Dong N, Qin G.   +13 more
europepmc   +1 more source

Ganoderic Acid A Attenuates Pathological Cardiac Hypertrophy by Attenuating Inflammatory Responses. [PDF]

Curr Issues Mol Biol
Zhen C, Zhang Y, Tan H, Liu D, He X, Chen W.   +5 more
europepmc   +1 more source